Answers are grounded in this paper and cite their sources.
A new series of glycosyl benzofuranylthiazole derivatives were designed, synthesized, characterized, and evaluated as potential candidates to treat Alzheimer’s disease. The compounds have been synthesized by the cyclocondensation of glycosyl thiourea with a variety of 2-(bromoacetyl)benzofurans. The reaction conditions have been optimized, and good yields (79–95%) have been obtained. The synthesized compounds showed different degrees of cholinesterase inhibitory activity.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: